Arecor Therapeutics plc (FRA:6UI)
0.8100
-0.0200 (-2.41%)
At close: Jan 30, 2026
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of €35.53 million as of January 30, 2026. Its market cap has increased by 36.01% in one year.
Market Cap
35.53M
Enterprise Value
33.56M
Revenue
5.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.81
Market Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 77.94M to 35.53M, a decrease of -54.41%. That is a compound annual growth rate of -15.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 35.53M | 1.99% |
| Dec 31, 2025 | 34.84M | 3.82% |
| Dec 31, 2024 | 33.56M | -47.90% |
| Dec 29, 2023 | 64.41M | -22.25% |
| Dec 30, 2022 | 82.85M | -37.50% |
| Dec 31, 2021 | 132.56M | 70.08% |
| Jun 3, 2021 | 77.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fair Value REIT-AG | 47.70M |
| PEH Wertpapier AG | 46.72M |
| Fernheizwerk Neukölln Aktiengesellschaft | 46.00M |
| U.C.A. Aktiengesellschaft | 40.51M |
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 36.86M |
| OTRS AG | 36.22M |
| edding AG | 35.48M |
| Readcrest Capital AG | 32.13M |